JAMA & Archives
SEARCH
GO TO ADVANCED SEARCH
-
HOME  SUBSCRIPTIONS  E-MAIL ALERTS  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP

Myasthenia Gravis

Contributing journals to this collection:
JAMA & Archives Journals

Citations 31-40 of 46 total displayed.

Past content

Arch Neurol
Original Contributions
Development of Generalized Disease at 2 Years in Patients With Ocular Myasthenia Gravis
Mark J. Kupersmith; Robert Latkany; Peter Homel
Arch Neurol 2003; 60: 243-248. [Abstract] [Full text] [PDF]  

Arch Neurol
Editorials
Therapies for Disorders of the Neuromuscular Junction
J. Ned Pruitt II; Thomas R. Swift
Arch Neurol 2002; 59: 739-742. [Extract] [Full text] [PDF]  

Arch Neurol
Editorials
Titin, Thymoma, and Myasthenia Gravis
Johan A. Aarli
Arch Neurol 2001; 58: 869-870. [Extract] [Full text] [PDF]  

Arch Neurol
Original Contributions
Anti-Titin Antibodies in Myasthenia Gravis: Tight Association With Thymoma and Heterogeneity of Nonthymoma Patients
Ana Maria Yamamoto; Philippe Gajdos; Bruno Eymard; Christine Tranchant; Jean-Marie Warter; Lucienne Gomez; Charles Bourquin; Jean-François Bach; Henri-Jean Garchon
Arch Neurol 2001; 58: 885-890. [Abstract] [Full text] [PDF]  

Arch Neurol
Original Contributions
The Severity of Myasthenia Gravis Correlates With the Serum Concentration of Titin and Ryanodine Receptor Antibodies
Fredrik Romi; Geir Olve Skeie; Johan A. Aarli; Nils Erik Gilhus
Arch Neurol 2000; 57: 1596-1600. [Abstract] [Full text] [PDF]  

Arch Neurol
Neurological Reviews
Current Treatment of Neuromuscular Diseases
Lisa Kokontis; Ludwig Gutmann
Arch Neurol 2000; 57: 939-943. [Extract] [Full text] [PDF]  

Arch Neurol
Controversies in Neurology
Treatment of Ocular Myasthenia With Corticosteroids: Yes
Mark A. Agius
Arch Neurol 2000; 57: 750-751. [Extract] [Full text] [PDF]  

Arch Neurol
Controversies in Neurology
Treatment of Ocular Myasthenia: Steroids Only When Compelled
Henry J. Kaminski; Robert B. Daroff
Arch Neurol 2000; 57: 752-753. [Extract] [Full text] [PDF]  

Arch Neurol
Controversies in Neurology
Treatment of Ocular Myasthenia
Vladimir Hachinski
Arch Neurol 2000; 57: 753. [Extract] [Full text] [PDF]  

Arch Neurol
Original Contributions
T-Lymphocyte Interferon-{gamma} Receptor Binding in Patients With Myasthenia Gravis
Paolo Bongioanni; Roberta Ricciardi; Maria Rosaria Romano
Arch Neurol 1999; 56: 933-938. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5

 Collections
 •Topic Collections Home
 •Related collections:
  •Neurology
  •Alzheimer Disease
  •Amyotrophic Lateral Sclerosis
  •Ataxia
  •Behavioral Neurology
  •Cerebrovascular Disease
  •Cognitive Disorders
  •Coma/ Vegetative State
  •Deep Brain Stimulation
  •Dementias
  •EEG
  •Encephalitis
  •Epilepsy
  •Functional Imaging
  •Headache
  •Lewy Body Disease
  •Meningitis
  •Migraine
  •Motor Neuron Disease
  •Movement Disorders
  •Multiple Sclerosis/ Demyelinating Disease
  •Myasthenia Gravis
  •Neurocutaneous Diseases
  •Neuroendocrinology
  •Neurogenetics
  •Neuroimaging
  •Neuromuscular diseases
  •Neuro-ophthalmology
  •Neuro-otology
  •Neuropathology
  •Neurotoxicology
  •Parkinson Disease/ Parkinsonian Disorders
  •Pediatric Neurology
  •Pick Disease
  •Prion Diseases
  •Seizures, Nonepileptic
  •Stroke
  •Tremor
  •Neurology, Other
Advertisement




HOME | SUBSCRIPTIONS | E-MAIL ALERTS | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.